Prehypertension: How Often This Cardiovascular Condition Occurs in Citizens of European Russia (EPOCH-AH, 2002–2007)

In recent years there has been actively discussed the problem of prehypertension since this arterial pressure level combined with three or more risk factors is a separate stratification index of cardiovascular incidence and mortality rate.

The aim of the investigation was to study the prehypertension prevalence depending on gender and age, state its dynamics and determine the frequency of combinations of various risk factors in European Russia population from 2002 till 2007.

Materials and Methods. Population in nine European Russian subjects was randomized in 2002. The respondents included in the sampling were examined by outpatient physicians. The prevalence of prehypertension and a number of risk factors in respondents were reanalyzed 2007.

Results. 286 outpatient physicians examined 6780 families (14 555 respondents). Prehypertension prevalence in 2002 was 13.7% of the population size, in 2007 the prevalence reached 16.9% (p<0.001). Prehypertension develops reliably more frequently in men than in women that subsequently predetermines earlier formation of arterial hypertension and cardiovascular complications. Age-specific prehypertension prevalence in RF increases in the period from 10 to 60 years, men preserving priority. The number of prehypertensive respondents with three and more risk factors did not change significantly over the period of five years and was 84.2% in 2002 and 65.2% — in 2007.

Conclusion. Prehypertension prevalence in the Russian Federation is high, over 60% of respondents have normal or high normal arterial pressure level and three and more hypertension risk factors that is a major medical and social problem for the country.

1. Lewington S., Clarke R., Qizilbash N., et al. Prospective Studies Collaboration: age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 Dec 14; 360: 1903–1913.
2. Wang J.G., Staessen J.A., Franklin S.S., et al. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcomes. Hypertension 2005 May; 45(5): 907–913.
3. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003 May 21; 289(19): 2560–2572.
4. Kannel W.B. Prevalence and implications of uncontrolled systolic hypertension. Drugs Aging 2003; 20(4): 277–286.
5. Wang Y., Wang Q.J. The prevalence of prehypertension and hypertension among US adults according to the New Joint National Committee Guidelines. Arch Intern Med 2004; 164: 2126–2134.
6. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. JAMA 2003; 289: 2363–2369.
7. Wolz M., Cutler J., Roccella E.J., et al. Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Am J Hypertens 2000; 13: 103–104.
8. Shalnova S.A., Balanova Yu.A., Konstantinov V.V., et al. Arterial’naya gipertoniya: rasprostranennost’, osvedomlennost’, priem antigipertenzivnykh preparatov i effektivnost’ lecheniya sredi naseleniya Rossiyskoy Federatsii [Arterial hypertension: prevalence, awareness, anti-hypertensive pharmaceutical treatment, treatment effectiveness in Russian population]. Ros Kardiol Z — Russian Cardiological Journal 2006; 4: 45–50.
9. Fomin I., Mareev V., Scherbinina E., Shustova T., Vasin S., Fadeeva I., Kosjanov A. The cardiovascular events by patients arterial hypertension in the European part of Russia; 10th European Meeting on Hypertension 29 May — 3 June 2000 Goteborg, Sweden. Journal of Hypertension 2000 June; 18(Suppl. 2): S170.
10. Mareev V.Yu., Fomin I.V., Shcherbinina E.V. Pokazateli rasprostranennosti arterial’noy gipertonii i effektivnost’ ee terapii v zavisimosti ot tyazhesti zabolevaniya [The indices of arterial hypertension prevalence and the efficiency of its therapy depending on the severity of the disease]. Serdechnaya nedostatochnost’ — Cardiac Failure 2002; 2: 69–70.
11. Perk J., De Backer G., Gohlke H., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). European Heart Journal 2012; 33: 1635–1701.
12. Mancia G., De Backer G., Dominiczak A., et al. Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2007: 28; 1462–1536.
13. Mancia G., Laurent S., Agabiti-Rosei E., et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Journal of Hypertension 2009; 27: 2121–2158.
14. Pepine C.J., Handberg E.M., Cooper-DeHoff R.M., et al. INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003; 290: 2805–2816.
15. Julius S., Kjeldsen S.E., Weber M., et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 2004; 363: 2022–2031.
16. Dahlof B., Sever P.S., Poulter N.R., Wedel H., et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895–906.
17. The ACCORD Study Group: effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 17: 1575–1585.
18. Ostchega Y., Yoon S.S., Hughes J., Louis T. Hypertension awareness, treatment, and control — continued disparities in adults: United States, 2005–2006. NCHS data brief no Hyattsville. MD: National Center for Health Statistics; 2008.
19. Vasan R.S., Larson M.G., Leip E.P., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291–1297.
20. Vasan R.S., Larson M.G., Leip E.P., Kannel W.B., Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682–1686.
21. Ageev F.T., Belenkov Yu.N., Fomin I.V., Mareev V.Yu., Scherbinina E.V., Badin Yu.V. Rasprostranennost’ arterial’noy gipertonii v Evropeyskoy chasti Rossiyskoy Federatsii — dannye EPOKhA [The prevalence of arterial hypertension in European Russia — EPOCH findings]. Serdtse — Heart 2005; 5: 38–42. 38–42.
22. Mareev V.Yu., Fomin I.V., Ageev F.T., Belenkov Yu.N., et al. Rasprostranennost’ faktorov riska sredi bol’nykh arterial’noy gipertoniey v Evropeyskoy chasti Rossiyskoy Federatsii [The prevalence of risk factors among patients with arterial hypertension in European Russia]. Serdechnaya nedostatochnost’ — Cardiac Failure 2004; 6: 282–284.
23. Diagnostika i lechenie arterial’noy gipertenzii Rekomendatsii Rossiyskogo meditsinskogo obshchestva po arterial’noy gipertonii i Vserossiyskogo nauchnogo obshchestva kardiologov [Diagnostics and management of arterial hypertension. Recommendations of Russian medical society for arterial hypertension and Russian Society of cardiology]. Kardiovaskulyarnaya terapiya i profilaktika — Cardiovascular Therapy and Prophylaxis 2008; Prilozhenie 2 [Supplement 2]; 7(6): 1–31.
24. Belenkov Yu.N., Fomin I.V., Badin Yu.V., Polyakov D.S., Mareev V.Yu., Ageev F.T., et al. Gendernye razlichiya v rasprostranennosti i effektivnosti lecheniya arterial’noy gipertenzii v Evropeyskoy chasti Rossiyskoy Federatsii: rezul’taty issledovaniya EPOKhA-2007 [Gender differences in prevalence and efficiency of treatment of arterial hypertension in European Russia: the findings of EPOCH-2007]. Problemy zhenskogo zdorov’ya — Problems of Women Health 2011; 4: 5–11.
25. Belenkov Yu.N., Fomin I.V., Mareev V.Yu., Ageev F.T., Scherbinina E.V., Badin Yu.V. Rasprostranennost’ i osobennosti terapii arterial’noy gipertonii u muzhchin i zhenshchin Evropeyskoy chasti RF. Dannye obsledovaniya reprezentativnoy vyborki (EPOKhA-AG) [The prevalence and characteristics of arterial hypertension therapy in men and women of European Russia. The representative sampling data (EPOCH-AH)]. Serdtse — Heart 2006; 1: 54–58.
26. Chobanian A.V., Bakris G.L., Black H.R., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
27. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.
28. Zhang Y., Lee E.T., Devereux R.B., et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the strong heart study. Hypertension 2006; 47: 410–414.
29. Greenlund K.J., Croft J.B., Mensah G.A. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999–2000. Arch Intern Med 2004; 164: 2113–2118.
30. Fomin I.V. Arterial’naya gipertoniya v Rossiyskoy Federatsii — poslednie 10 let. Chto dal’she? [Arterial hypertension in the Russian Federation – the past 10 years. What comes next?]. Serdtse — Heart 2007; 6(3): 1–6.
31. Edinaya mezhvedomstvennaya informatsionno-statisticheskaya sistema. Chislennost’ postoyannogo naseleniya na 1 yanvarya (chelovek) 1990–2010 gody [Unified interdepartmental information statistical system. The resident population as of January, 1 (people) 1990–2010]. http: //www.fedstat.ru/indicators/start.do

Fomin I.V., Badin Y.V., Polyakov D.S., Belenkov Y.N., Mareev V.Y., Ageev F.Т., Artemieva Е.G., Galyavich А.S., Kamalov G.М., Kechedzhieva S.G., Koziolova N.А., Malenkova V.Y., Podzemelnikov Е.V., Saifutdinov R.I., Smirnova Е.А., Tarlovskaya Е.I., Scherbinina Е.V., Yakushin S.S. Prehypertension: How Often This Cardiovascular Condition Occurs in Citizens of European Russia (EPOCH-AH, 2002–2007). Sovremennye tehnologii v medicine 2013; 5(2): 38